| 1 |
31528826 | Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition. | 2019 Oct 1 |
1 |
| 2 |
24516103 | Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. | 2014 May |
1 |
| 3 |
16253158 | [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure]. | 2005 Jul 6 |
2 |
| 4 |
14716224 | AT1 and AT2-receptor antagonists inhibit Ang II-mediated facilitation of noradrenaline release in human atria. | 2004 Feb |
1 |
| 5 |
12729939 | Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics. | 2003 May |
2 |
| 6 |
12817186 | Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjects. | 2003 Jul |
1 |
| 7 |
12829196 | Effects of enalaprilat on venoconstriction to norepinephrine: role of prostaglandins. | 2003 Jul 1 |
1 |
| 8 |
10797820 | [Refractory shock after converting enzyme inhibitor administration. Usefulness of angiotensin II]. | 2000 Apr 8 |
1 |
| 9 |
10549404 | Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. | 1999 Oct |
1 |
| 10 |
9550640 | Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM. | 1998 Mar |
2 |
| 11 |
9612217 | Structure and in vitro function of human subcutaneous small arteries in mild heart failure. | 1998 May |
1 |
| 12 |
9218207 | Angiotensin converting enzyme inhibitor-calcium antagonist combination: an alliance for cardioprotection? | 1997 Mar |
1 |
| 13 |
9286946 | Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. | 1997 Aug 19 |
1 |
| 14 |
9383175 | Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect of bradykinin in human right atrium. | 1997 Nov |
2 |
| 15 |
8681492 | Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects. | 1996 Jun |
1 |
| 16 |
8814528 | [How and to what extent has beta-blocker treatment been established for chronic heart failure?]. | 1996 Aug |
2 |
| 17 |
8906519 | Effects of angiotensin converting enzyme inhibitor on renal haemodynamics during mental stress. | 1996 Oct |
1 |
| 18 |
11862256 | Neurohumoral Mechanisms in Congestive Heart Failure and the Role of Drugs with Multiple Actions: A Review of Carvedilol. | 1996 Mar |
1 |
| 19 |
7882823 | Enhanced pressor responsiveness to norepinephrine in type II diabetes. Effect of ACE inhibition. | 1994 Dec |
2 |
| 20 |
8024910 | ACE inhibitor premedication attenuates sympathetic responses during surgery. | 1994 Jun |
2 |
| 21 |
8293770 | Modulation of sympathetic control by ACE inhibitors. | 1993 Nov |
1 |
| 22 |
8390529 | Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man. | 1993 May |
1 |
| 23 |
8403943 | [Drug therapy of chronic congestive heart failure: the why and how]. | 1993 |
2 |
| 24 |
8485825 | Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action. | 1993 May |
1 |
| 25 |
1433167 | ACE inhibition in diabetic patients: effect on pressor responsiveness to noradrenaline. | 1992 Aug |
1 |
| 26 |
1473654 | [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor]. | 1992 Jul |
1 |
| 27 |
1559192 | The pharmacodynamic responses of hypertensive patients to quinapril therapy. | 1992 Mar |
1 |
| 28 |
2483232 | Protection of the myocardium against postischemic reperfusion damage. | 1989 |
1 |
| 29 |
2670220 | ACE inhibitors in congestive heart failure. | 1989 |
1 |
| 30 |
2685117 | Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. | 1989 Oct |
1 |
| 31 |
2839312 | Angiotensin converting enzyme activity in the amygdaloid complex in a neurogenic hypertensive model. | 1988 |
1 |
| 32 |
3049097 | Converting enzyme inhibitors in heart failure. | 1988 Jun |
2 |
| 33 |
7027386 | [Effects of angiotensin I converting enzyme inhibitor, captopril, on plasma norepinephrine concentration in hypertensive patients (author's transl)]. | 1981 Jul |
1 |